These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 24450444)
1. Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study. Blasi F; Ostermann H; Racketa J; Medina J; McBride K; Garau J; Respir Res; 2014 Jan; 15(1):6. PubMed ID: 24450444 [TBL] [Abstract][Full Text] [Related]
2. Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study. Garau J; Blasi F; Medina J; McBride K; Ostermann H; BMC Infect Dis; 2015 Feb; 15():78. PubMed ID: 25879713 [TBL] [Abstract][Full Text] [Related]
3. Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Blasi F; Garau J; Medina J; Ávila M; McBride K; Ostermann H; Respir Res; 2013 Apr; 14(1):44. PubMed ID: 23586347 [TBL] [Abstract][Full Text] [Related]
4. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study. Ostermann H; Blasi F; Medina J; Pascual E; McBride K; Garau J; J Med Econ; 2014 Oct; 17(10):719-29. PubMed ID: 24983206 [TBL] [Abstract][Full Text] [Related]
5. Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study. Ostermann H; Garau J; Medina J; Pascual E; McBride K; Blasi F; BMC Pulm Med; 2014 Mar; 14():36. PubMed ID: 24593248 [TBL] [Abstract][Full Text] [Related]
6. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia. Belforti RK; Lagu T; Haessler S; Lindenauer PK; Pekow PS; Priya A; Zilberberg MD; Skiest D; Higgins TL; Stefan MS; Rothberg MB Clin Infect Dis; 2016 Jul; 63(1):1-9. PubMed ID: 27048748 [TBL] [Abstract][Full Text] [Related]
7. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial. Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M; JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708 [TBL] [Abstract][Full Text] [Related]
8. Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009. Berger A; Edelsberg J; Oster G; Huang X; Weber DJ Am J Med Sci; 2014 May; 347(5):347-56. PubMed ID: 24029796 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia. Akram AR; Chalmers JD; Taylor JK; Rutherford J; Singanayagam A; Hill AT Clin Microbiol Infect; 2013 Dec; 19(12):1174-80. PubMed ID: 23438068 [TBL] [Abstract][Full Text] [Related]
11. Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia. Marcos PJ; Restrepo MI; Sanjuàn P; Ferreira-Gonzalez L; Verea-Hernando H Hosp Pract (1995); 2013 Aug; 41(3):7-14. PubMed ID: 23948616 [TBL] [Abstract][Full Text] [Related]
12. [Patients hospitalized with community-acquired pneumonia: a comparative study of outcomes by medical specialty area]. Capelastegui A; España PP; Quintana JM; Gorordo I; Martínez Urquiri A; Idoiaga I; Bilbao A Arch Bronconeumol; 2005 Jun; 41(6):300-6. PubMed ID: 15989886 [TBL] [Abstract][Full Text] [Related]
13. Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study. Høgli JU; Garcia BH; Svendsen K; Skogen V; Småbrekke L BMC Pulm Med; 2020 Jun; 20(1):169. PubMed ID: 32539706 [TBL] [Abstract][Full Text] [Related]
14. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study. Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913 [TBL] [Abstract][Full Text] [Related]
15. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection. Wongsurakiat P; Chitwarakorn N BMC Pulm Med; 2019 Oct; 19(1):179. PubMed ID: 31619219 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI). Kuzman I; Bezlepko A; Kondova Topuzovska I; Rókusz L; Iudina L; Marschall HP; Petri T BMC Pulm Med; 2014 Jun; 14():105. PubMed ID: 24975809 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia. Stein GE; Mantz SL Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526 [TBL] [Abstract][Full Text] [Related]
18. Comparison of processes and outcomes of pneumonia care between hospitalists and community-based primary care physicians. Rifkin WD; Conner D; Silver A; Eichorn A Mayo Clin Proc; 2002 Oct; 77(10):1053-8. PubMed ID: 12374249 [TBL] [Abstract][Full Text] [Related]
20. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study. Garau J; Ostermann H; Medina J; Avila M; McBride K; Blasi F; Clin Microbiol Infect; 2013 Sep; 19(9):E377-85. PubMed ID: 23663184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]